Travere Therapeutics TVTX
NASDAQ TVTX
$56.93 +0.08 (+0.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Price to Earnings (2015 - 2016)

Updated

Travere Therapeutics' (TVTX) Price to Earnings came in at 6.48 for Q2 2016, up 15.1% from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Price to Earnings (2015 - 2016) Analysis & Trends

For FY2015, Travere Therapeutics' Price to Earnings stood at 6.00.

  • Quarterly Price to Earnings has run from a low of 5.63 in Q1 2016 to a high of 146.13 in Q1 2015 over five years.
  • According to Business Quant data, Price to Earnings for the three prior quarters was 5.63 (Q1 2016), 6.00 (Q4 2015) and 8.08 (Q3 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Travere Therapeutics 5.36 Bn 4.96 Bn 167.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 6.48
Mar 31, 2016 5.63
Dec 31, 2015 6.00
Sep 30, 2015 8.08
Mar 31, 2015 146.13
API Access

Travere Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=TVTX&period=max&api_key=YOUR_API_KEY